Literature DB >> 29136822

New Ti-IMAC magnetic polymeric nanoparticles for phosphopeptide enrichment from complex real samples.

Anna Laura Capriotti1, Chiara Cavaliere2, Francesca Ferraris3, Valentina Gianotti4, Michele Laus5, Susy Piovesana6, Katia Sparnacci7, Riccardo Zenezini Chiozzi8, Aldo Laganà9.   

Abstract

The work describes the preparation of a new magnetic phase for batch enrichment of phosphopeptides. The material exploits the advantages of magnetic solid phase extraction and couples them with the most employed approach for phosphopeptide enrichment, i.e. Ti4+-IMAC. In order to immobilize Ti4+ ions on the surface of the magnetite nanoparticles, they were first covered by a silica shell and then modified to expose at the surface bromine containing groups. Glycidyl methacrylate was subsequently polymerized from these groups using the "grafting from" approach by the activator regenerated by electron transfer-atom transfer radical polymerization (ARGET-ATRP) technique. Finally, the glycidyl groups were reacted with iminodiacetic acid to functionalize the material with moieties suitable for coordination. The prepared material was extensively characterized and subsequently tested for enrichment of a bovine serum albumin mixture with casein to ascertain its potential. With positive results, the new magnetic polymeric material was further employed to set up an enrichment method on yeast protein digest based on shotgun proteomics. The sample to phase ratio was optimized and the best condition compared to a commercial TiO2 spin column. At the end of the comparison, the new material proved better and could enrich a larger total number of phosphopeptides with increased selectivity. All these conclusions and the test performed on a real complex sample within the final shotgun application further support the applicability of the new material in phosphopeptide analysis of real matrices.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Magnetic nanoparticles; NanoHPLC-M/MS; Phosphopeptide enrichment; Phosphoproteomics; Ti-IMAC

Mesh:

Substances:

Year:  2017        PMID: 29136822     DOI: 10.1016/j.talanta.2017.09.010

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  6 in total

1.  A porous graphene sorbent coated with titanium(IV)-functionalized polydopamine for selective lab-in-syringe extraction of phosphoproteins and phosphopeptides.

Authors:  Siyuan Tan; Jundong Wang; Qiang Han; Qionglin Liang; Mingyu Ding
Journal:  Mikrochim Acta       Date:  2018-06-06       Impact factor: 5.833

Review 2.  Post-Translational Modifications of Histones Are Versatile Regulators of Fungal Development and Secondary Metabolism.

Authors:  Aurelie Etier; Fabien Dumetz; Sylvain Chéreau; Nadia Ponts
Journal:  Toxins (Basel)       Date:  2022-04-29       Impact factor: 5.075

3.  A New Strategy for High-Efficient Tandem Enrichment and Simultaneous Profiling of N-Glycopeptides and Phosphopeptides in Lung Cancer Tissue.

Authors:  Zhuokun Du; Qianying Yang; Yuanyuan Liu; Sijie Chen; Hongxian Zhao; Haihong Bai; Wei Shao; Yangjun Zhang; Weijie Qin
Journal:  Front Mol Biosci       Date:  2022-05-24

4.  Protein phosphorylation networks in spargana of Spirometra erinaceieuropaei revealed by phosphoproteomic analysis.

Authors:  Wei Liu; Hailin Tang; Asmaa M I Abuzeid; Lei Tan; Aibing Wang; Xueping Wan; Haoji Zhang; Yisong Liu; Guoqing Li
Journal:  Parasit Vectors       Date:  2020-05-13       Impact factor: 3.876

5.  Facile fabrication of mesostructured natural rubber/silica nanocomposites with enhanced thermal stability and hydrophobicity.

Authors:  Supphathee Chaowamalee; Chawalit Ngamcharussrivichai
Journal:  Nanoscale Res Lett       Date:  2019-12-17       Impact factor: 4.703

6.  Analysis of Proteomic Characteristics of Peripheral Blood in Preeclampsia and Study of Changes in Fetal Arterial Doppler Parameters Based on Magnetic Nanoparticles.

Authors:  Xundan Zhou; Lei Qu; Wenting Zhang; Fang Yang; Xiaoxia Hou; Shaoli Wang
Journal:  Comput Math Methods Med       Date:  2021-11-02       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.